Home » Stocks » IQV

IQVIA Holdings Inc. (IQV)

Stock Price: $231.78 USD -2.62 (-1.12%)
Updated May 10, 2021 3:17 PM EDT - Market open
Market Cap 44.92B
Revenue (ttm) 12.01B
Net Income (ttm) 409.00M
Shares Out 191.50M
EPS (ttm) 2.10
PE Ratio 110.37
Forward PE 27.93
Dividend n/a
Dividend Yield n/a
Trading Day May 10
Last Price $231.78
Previous Close $234.39
Change ($) -2.62
Change (%) -1.12%
Day's Open 234.96
Day's Range 231.28 - 235.86
Day's Volume 566,179
52-Week Range 128.52 - 237.47

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

IQVIA (IQV) could produce exceptional returns because of its solid growth attributes.

1 week ago - Zacks Investment Research

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE: IQV) announced today that it will collaborate with Corium, Inc – a commercial-stage biopharmaceutical company leading the development and comm...

1 week ago - Business Wire

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Global spending on medicines — using invoice price levels — is expected to grow at 3-6 percent CAGR through 2025 to reach about $1.6 trillion by 2025, excl...

1 week ago - Business Wire

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE: IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, tod...

1 week ago - Business Wire

IQVIA (IQV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

2 weeks ago - Zacks Investment Research

IQVIA's (IQV) first-quarter 2021 earnings and revenues increase year over year.

2 weeks ago - Zacks Investment Research

IQVIA (IQV) delivered earnings and revenue surprises of 17.84% and 7.47%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 weeks ago - Zacks Investment Research

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA revenue for the first quarter of $3,409 million increased 23.8 percent on a reported basis and 21.4 percent at constant currency

2 weeks ago - Business Wire

IQVIA's (IQV) first-quarter 2021 earnings and revenues are expected to have improved year over year.

2 weeks ago - Zacks Investment Research

IQVIA Holdings (IQV) has been benefiting from consecutive better-than-expected top- and bottom-line performances, and encouraging yearly EPS guidance.

1 month ago - Zacks Investment Research

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its first-quarter 2021 financial results before the market opens on Thursday, April 22, 2021. The IQ...

1 month ago - Business Wire

IQVIA (IQV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

1 month ago - Zacks Investment Research

The latest deal is expected to help IQVIA (IQV) strengthen its Research & Development Solutions segment.

1 month ago - Zacks Investment Research

SECAUCUS, N.J. and RESEARCH TRIANGLE PARK, N.C.

Other stocks mentioned: DGX
1 month ago - PRNewsWire

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research ser...

Other stocks mentioned: DGX
1 month ago - Business Wire

IQVIA Holdings (IQV) rises on consistent shareholder-friendly measures and strong healthcare-specific infrastructures. Meanwhile,the company's debt-laden balance sheet is a concern.

1 month ago - Zacks Investment Research

IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?

1 month ago - Zacks Investment Research

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV) announced today that more than 60 trials spanning over 40 countries utilize its innovative decentralized clinical trial ...

2 months ago - Business Wire

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C--(BUSINESS WIRE)--IQVIA™ (NYSE: IQV) announces that since September 2020 it has been collaborating with Janssen Research & Development, LLC, one of the Janss...

2 months ago - Business Wire

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will p...

2 months ago - Business Wire

IQVIA (IQV) has a strong healthcare-specific global IT infrastructure, analytics-driven clinical development capabilities and a robust real-world solutions ecosystem.

2 months ago - Zacks Investment Research

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering o...

2 months ago - Business Wire

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV) today announced that 140 life science companies in nearly 90 countries have selected Orchestrated Customer Engagement (OC...

2 months ago - Business Wire

IQVIA's (IQV) fourth-quarter 2020 revenues and earnings increase year over year.

3 months ago - Zacks Investment Research

IQVIA (IQV) delivered earnings and revenue surprises of 4.98% and 4.68%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

IQVIA's (IQV) fourth-quarter 2020 earnings and revenues are expected to have improved year over year.

3 months ago - Zacks Investment Research

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE: IQV) today announced that it has been recognized as a top performer by survey respondents in Industry Standard Research's eC...

3 months ago - Business Wire

IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) has been named to FORTUNE magazine's “World's Most Admired Companies” list. IQVIA has received t...

3 months ago - Business Wire

IQVIA demonstrates a strong sequential growth pattern, in near recovery to pre-pandemic volumes. Management have reinstated the buyback program, with ~$1 billion in authorization, and look set on acquis...

3 months ago - Seeking Alpha

Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from it. So insider buying can b...

Other stocks mentioned: DNMR, LNG, CQP, FNF, IEP, ODT, SPLP
4 months ago - Benzinga

Over halfway through the trading day on Tuesday, and the broad markets have yet to make up their minds.

Other stocks mentioned: BIIB, PEAK, LESL
4 months ago - 24/7 Wall Street

MORRISVILLE, N.C.--(BUSINESS WIRE)--Q2 Solutions, a leading global clinical trial laboratory services organization, resulting from an IQVIA and Quest Diagnostics joint venture, today announced a partner...

4 months ago - Business Wire

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life scienc...

4 months ago - Business Wire

IQVIA Holdings (IQV) stock has been benefiting from consecutive better-than-expected top- and bottom-line performances and encouraging yearly guidance.

5 months ago - Zacks Investment Research

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE: IQV) said today that it is pleased to be a supporter of the Real World Evidence Leadership Forum, a group consisting of seni...

5 months ago - Business Wire

IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?

5 months ago - Zacks Investment Research

Consecutive better-than-expected top- and bottom-line performances, encouraging yearly guidance and shareholder friendly moves have been aiding IQVIA Holdings (IQV) stock.

6 months ago - Zacks Investment Research

IQVIA Holdings Inc. (IQV) CEO Ari Bousbib on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

IQVIA's (IQV) third-quarter 2020 revenues and earnings increase year over year.

6 months ago - Zacks Investment Research

IQVIA (IQV) delivered earnings and revenue surprises of 7.95% and 1.29%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Shares of IQVIA Holdings (NYSE:IQV) rose 3% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 1.87% over the past year to $1.63, which beat the estim...

6 months ago - Benzinga

IQVIA Holdings (IQV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

6 months ago - Zacks Investment Research

IQVIA's (IQV) third-quarter 2020 earnings and revenues are expected to have declined year over year.

6 months ago - Zacks Investment Research

IQVIA (IQV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

IQVIA Holdings (IQV) stock has been benefiting from consecutive better-than-expected top- and bottom-line performances and encouraging yearly guidance.

6 months ago - Zacks Investment Research

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE: IQV), in scientific partnership with the U.S. Food and Drug Administration, will provide agile analytics from IQVIA’s CARE P...

6 months ago - Business Wire

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), will announce its third-quarter financial results before the market opens on Tuesday, October 2...

7 months ago - Business Wire

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.

7 months ago - Business Wire

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.

8 months ago - Business Wire

About IQV

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and dissemin... [Read more...]

Industry
Diagnostics & Research
IPO Date
May 9, 2013
CEO
Ari Bousbib
Employees
72,000
Stock Exchange
NYSE
Ticker Symbol
IQV
Full Company Profile

Financial Performance

In 2020, IQVIA Holdings's revenue was $11.36 billion, an increase of 2.44% compared to the previous year's $11.09 billion. Earnings were $279.00 million, an increase of 46.07%.

Financial Statements

Analyst Forecasts

According to 21 analysts, the average rating for IQVIA Holdings stock is "Buy." The 12-month stock price forecast is 256.32, which is an increase of 10.59% from the latest price.

Price Target
$256.32
(10.59% upside)
Analyst Consensus: Buy